Genting New Excellence: Nufucan's patent litigation made positive progress.

On February 27, Cloud Top New Shining announced that the company's original research product, Budesonide Enteric Capsule, made a key progress in patent protection. The Guangzhou Intellectual Property Court issued a civil ruling on February 26, 2026, fully supporting the company's pre-litigation asset preservation application and ordering the relevant generic drug companies to immediately stop infringing actions and stop listing on the market. The ruling is effective immediately from the date of issuance.